Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Study of Human Botulism Immunoglobulin (BabyBIG) in Infants With Botulism
NCT00004401Phase 3Completed
- Sponsor
- California Department of Health Services
- Start
- Jan 1998
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of Botulism Immune Globulin Intravenous (Human) in botulism, sponsored by California Department of Health Services. Started Jan 1998; status: completed.
02
Drugs
Botulism Immune Globulin Intravenous (Human)
03
Conditions
botulism
Beyond the preview
Go deeper on NCT00004401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004401.